Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
about
Taking Advantage of Nature's Gift: Can Endogenous Neural Stem Cells Improve Myelin Regeneration?Current and Emerging Uses of Statins in Clinical Therapeutics: A ReviewCirculating immune cells in multiple sclerosis.Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis.Both cladribine and alemtuzumab may effect MS via B-cell depletionTGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis.Viral-induced suppression of self-reactive T cells: Lessons from neurotropic coronavirus-induced demyelination.Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.Neurological and psychiatric associations in bullous pemphigoid - more than skin deep?JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation.Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions.Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease.
P2860
Q28072282-AC125CE9-CCAC-4C75-9CFF-C690599DE000Q28076346-F78679D7-2BC5-4E4F-B30E-34CCA68BAF37Q30242026-E97F48F7-8AAA-418A-96CF-54924FB040F8Q38372016-45763946-E109-49C9-9F4B-DF699ED8469BQ38720045-C7BDBA79-E89E-4348-9DA6-054BF18C7EC2Q39094862-D8E683DC-6F7F-46DC-A082-38AA2CBF188AQ39096824-4B119688-2599-4DA8-BCBD-BF4E0A51F5C2Q39119839-17899CA1-9A90-4010-9A7C-F1BF7870BA79Q39414522-B64CF5F4-8365-4E73-A718-1470FABE8328Q47439880-33E1FB21-797A-4F55-B010-20DC91647A77Q47552983-5AD6374B-2439-4D8F-B099-8D33F718D11FQ48556502-003980C7-A6B0-4716-97AD-C469F46A017DQ52096273-BDDA0FD2-0A38-4F92-B1F6-00390ADB8C5EQ54937236-99AD3A81-2A3B-4ACA-9806-7E03CAF8EC78Q55027295-DD898F96-6C3E-4DEA-8DEC-24D8D490DF34
P2860
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Current multiple sclerosis tre ...... of MS autoimmune pathogenesis.
@en
type
label
Current multiple sclerosis tre ...... of MS autoimmune pathogenesis.
@en
prefLabel
Current multiple sclerosis tre ...... of MS autoimmune pathogenesis.
@en
P2093
P2860
P50
P356
P1476
Current multiple sclerosis tre ...... of MS autoimmune pathogenesis.
@en
P2093
Britta Engelhardt
Maria Rosito
Mireia Sospedra
Roland Martin
P2860
P304
P356
10.1002/EJI.201646485
P407
P577
2016-07-28T00:00:00Z